QBE the Americas has continued to see the fruits of its
"exclusive" primary property cat deal with Aon in the US,
with premiums booked under the arrangement thought to have topped
$50mn in the first quarter alone.
According to sources, deals written by the Australian-parented unit include a 10 percent ground-up quota share on the pharmaceutical giant Pfizer's $1bn property programme in the US.
As previously revealed by this publication, QBE's New York-headquartered subsidiary is on an aggressive drive to...
You are currently viewing an incomplete version of this article. If you are a subscriber then please login now. If you are a non-subscriber but would like to be able to view this article, then please select from the purchasing options below.